India
· Delayed Price · Currency is INR Thyrocare Technologies Statistics
Total Valuation
Thyrocare Technologies has a market cap or net worth of INR 45.06 billion. The enterprise value is 43.69 billion.
| Market Cap | 45.06B |
| Enterprise Value | 43.69B |
Important Dates
The next estimated earnings date is Wednesday, October 23, 2024.
| Earnings Date | Oct 23, 2024 |
| Ex-Dividend Date | Aug 16, 2024 |
Share Statistics
Thyrocare Technologies has 52.95 million shares outstanding. The number of shares has decreased by -0.32% in one year.
| Shares Outstanding | 52.95M |
| Shares Change (YoY) | -0.32% |
| Shares Change (QoQ) | +6.70% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 15.32% |
| Float | 15.20M |
Valuation Ratios
The trailing PE ratio is 57.98 and the forward PE ratio is 43.03. Thyrocare Technologies's PEG ratio is 1.72.
| PE Ratio | 57.98 |
| Forward PE | 43.03 |
| PS Ratio | 7.57 |
| PB Ratio | 8.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | 1.72 |
Enterprise Valuation
| EV / Earnings | 56.28 |
| EV / Sales | 7.36 |
| EV / EBITDA | 29.55 |
| EV / EBIT | 45.07 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 8.02 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | n/a |
| Interest Coverage | 22.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 10.75% |
| Revenue Per Employee | 3.51M |
| Profits Per Employee | 458,535 |
| Employee Count | 1,693 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.40% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +50.40% |
| 50-Day Moving Average | 777.76 |
| 200-Day Moving Average | 664.54 |
| Relative Strength Index (RSI) | 55.62 |
| Average Volume (20 Days) | 15,976 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Thyrocare Technologies had revenue of INR 5.94 billion and earned 776.30 million in profits. Earnings per share was 14.68.
| Revenue | 5.94B |
| Gross Profit | 3.11B |
| Operating Income | 970.20M |
| Pretax Income | 1.05B |
| Net Income | 776.30M |
| EBITDA | 1.48B |
| EBIT | 970.20M |
| Earnings Per Share (EPS) | 14.68 |
Balance Sheet
The company has 1.80 billion in cash and 423.40 million in debt, giving a net cash position of 1.38 billion or 25.99 per share.
| Cash & Cash Equivalents | 1.80B |
| Total Debt | 423.40M |
| Net Cash | 1.38B |
| Net Cash Per Share | 25.99 |
| Equity (Book Value) | 5.28B |
| Book Value Per Share | 104.88 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.38%, with operating and profit margins of 16.34% and 13.07%.
| Gross Margin | 52.38% |
| Operating Margin | 16.34% |
| Pretax Margin | 17.62% |
| Profit Margin | 13.07% |
| EBITDA Margin | 24.91% |
| EBIT Margin | 16.34% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 2.10%.
| Dividend Per Share | 18.00 |
| Dividend Yield | 2.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.32% |
| Shareholder Yield | 2.42% |
| Earnings Yield | 1.72% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |